A new scientific study points to a natural way for improving the immune system. According to an article published in the journal Acta Oncologica, treatment with the natural antiviral supplement Gene-Eden returned the number of immune cells to normal levels in a pancreatic cancer patient with a weak immune system. The study was conducted at the Center for the Biology of Chronic Disease by Hanan Polansky and Ido Dafni. Acta Oncologica is a leading scientific journal in clinical oncology and related disciplines, and the official journal of the five Nordic oncological societies.
Pancreatic cancer is a devastating disease. Almost no one recovers from it. In United States alone, physicians diagnose more than 40,000 new cases of pancreatic cancer each year, and more than 35,000 die from it annually. The known treatments are mostly ineffective. Although doctors try surgical removal of the tumor (for a localized tumor), chemotherapy, and radiation therapy, less than 5 out of a 100 patients are still alive 5 years from diagnosis.
The patient in the study was a 61 years old female, who was diagnosed with an inoperable pancreatic tumor. After two months of chemotherapy, which had no effect on the tumor growth, yet caused a sharp decline the number of immune cells, the treatment was replaced with a second-line chemotherapy, which is used for relieving symptoms rather than shrinking tumor. In addition, the patient was treated with Gene-Eden. Five weeks later, to the great surprise of the medical staff, a CT scan and some blood tests showed that the tumor shrank by 34%, and that the number of immune cells returned normal levels!
Gene-Eden is a broad range antiviral supplement that targets viruses during their latent or chronic phase. The development of Gene-Eden was inspired by Hanan Polansky's discovery of the Starved Gene phenomenon. According to Polansky, common viruses, such as the Hepatitis Virus, (Hep B virus, Hep C virus, HBV, HCV), Epstein Barr Virus (EBV), Herpes Simplex Virus (HSV), and Cytomegalovirus (CMV), to name a few, are genetic parasites. After they plant themselves in the nucleus, they "steal" needed resourced from the human genes. The starved human genes produce less proteins, such as Retinoblastoma (Rb) and BRCA1, and the cell can no longer control its rate of replication. The result is excessive cell replication and development of tumors.
For a more detailed explanation of the Starved Gene discovery, specifically formulated for the general public, see http://www.gene-eden.com/Gene-Eden.htm.
The Starved Gene discovery teaches us that chronic viruses can cause many major diseases, including pancreatic cancer. It also shows us that an antiviral treatment against chronic viruses should be effective in treating these diseases. According to the authors, the results of this study confirm the discovery. They show that that by targeting the chronic viruses in the patient's body, Gene-Eden can improve the patient's condition, to the great surprise of those unfamiliar with Dr. Polansky's discovery.
Study: "Gene-Eden, a broad range, natural antiviral supplement, may shrink tumors and strengthen the immune system" Hanan Polansky, Ido Dafni. Acta Oncologica; Posted online on 8 Jan 2010. - 32498
Pancreatic cancer is a devastating disease. Almost no one recovers from it. In United States alone, physicians diagnose more than 40,000 new cases of pancreatic cancer each year, and more than 35,000 die from it annually. The known treatments are mostly ineffective. Although doctors try surgical removal of the tumor (for a localized tumor), chemotherapy, and radiation therapy, less than 5 out of a 100 patients are still alive 5 years from diagnosis.
The patient in the study was a 61 years old female, who was diagnosed with an inoperable pancreatic tumor. After two months of chemotherapy, which had no effect on the tumor growth, yet caused a sharp decline the number of immune cells, the treatment was replaced with a second-line chemotherapy, which is used for relieving symptoms rather than shrinking tumor. In addition, the patient was treated with Gene-Eden. Five weeks later, to the great surprise of the medical staff, a CT scan and some blood tests showed that the tumor shrank by 34%, and that the number of immune cells returned normal levels!
Gene-Eden is a broad range antiviral supplement that targets viruses during their latent or chronic phase. The development of Gene-Eden was inspired by Hanan Polansky's discovery of the Starved Gene phenomenon. According to Polansky, common viruses, such as the Hepatitis Virus, (Hep B virus, Hep C virus, HBV, HCV), Epstein Barr Virus (EBV), Herpes Simplex Virus (HSV), and Cytomegalovirus (CMV), to name a few, are genetic parasites. After they plant themselves in the nucleus, they "steal" needed resourced from the human genes. The starved human genes produce less proteins, such as Retinoblastoma (Rb) and BRCA1, and the cell can no longer control its rate of replication. The result is excessive cell replication and development of tumors.
For a more detailed explanation of the Starved Gene discovery, specifically formulated for the general public, see http://www.gene-eden.com/Gene-Eden.htm.
The Starved Gene discovery teaches us that chronic viruses can cause many major diseases, including pancreatic cancer. It also shows us that an antiviral treatment against chronic viruses should be effective in treating these diseases. According to the authors, the results of this study confirm the discovery. They show that that by targeting the chronic viruses in the patient's body, Gene-Eden can improve the patient's condition, to the great surprise of those unfamiliar with Dr. Polansky's discovery.
Study: "Gene-Eden, a broad range, natural antiviral supplement, may shrink tumors and strengthen the immune system" Hanan Polansky, Ido Dafni. Acta Oncologica; Posted online on 8 Jan 2010. - 32498
About the Author:
More information on Gene-Eden is available at the Gene-Eden website. Gene-Eden is available on Amazon.com.
